Copyright Reports & Markets. All rights reserved.

Global Tuberculosis Screening Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Tuberculosis Screening by Type
    • 1.3.1 Overview: Global Tuberculosis Screening Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Tuberculosis Screening Consumption Value Market Share by Type in 2025
    • 1.3.3 Active Tuberculosis
    • 1.3.4 Latent Tuberculosis
  • 1.4 Global Tuberculosis Screening Market by Application
    • 1.4.1 Overview: Global Tuberculosis Screening Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Diagnostic Center
    • 1.4.5 Laboratories
    • 1.4.6 Others
  • 1.5 Global Tuberculosis Screening Market Size & Forecast
  • 1.6 Global Tuberculosis Screening Market Size and Forecast by Region
    • 1.6.1 Global Tuberculosis Screening Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Tuberculosis Screening Market Size by Region, (2021-2032)
    • 1.6.3 North America Tuberculosis Screening Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Tuberculosis Screening Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Tuberculosis Screening Market Size and Prospect (2021-2032)
    • 1.6.6 South America Tuberculosis Screening Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Tuberculosis Screening Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Qiagen
    • 2.1.1 Qiagen Details
    • 2.1.2 Qiagen Major Business
    • 2.1.3 Qiagen Tuberculosis Screening Product and Solutions
    • 2.1.4 Qiagen Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Qiagen Recent Developments and Future Plans
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Tuberculosis Screening Product and Solutions
    • 2.2.4 Sanofi Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sanofi Recent Developments and Future Plans
  • 2.3 Oxford Immunotec
    • 2.3.1 Oxford Immunotec Details
    • 2.3.2 Oxford Immunotec Major Business
    • 2.3.3 Oxford Immunotec Tuberculosis Screening Product and Solutions
    • 2.3.4 Oxford Immunotec Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Oxford Immunotec Recent Developments and Future Plans
  • 2.4 BioMerieux
    • 2.4.1 BioMerieux Details
    • 2.4.2 BioMerieux Major Business
    • 2.4.3 BioMerieux Tuberculosis Screening Product and Solutions
    • 2.4.4 BioMerieux Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 BioMerieux Recent Developments and Future Plans
  • 2.5 Par Sterile
    • 2.5.1 Par Sterile Details
    • 2.5.2 Par Sterile Major Business
    • 2.5.3 Par Sterile Tuberculosis Screening Product and Solutions
    • 2.5.4 Par Sterile Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Par Sterile Recent Developments and Future Plans
  • 2.6 Bio-Rad Laboratories
    • 2.6.1 Bio-Rad Laboratories Details
    • 2.6.2 Bio-Rad Laboratories Major Business
    • 2.6.3 Bio-Rad Laboratories Tuberculosis Screening Product and Solutions
    • 2.6.4 Bio-Rad Laboratories Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.7 Akonni Biosystems
    • 2.7.1 Akonni Biosystems Details
    • 2.7.2 Akonni Biosystems Major Business
    • 2.7.3 Akonni Biosystems Tuberculosis Screening Product and Solutions
    • 2.7.4 Akonni Biosystems Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Akonni Biosystems Recent Developments and Future Plans
  • 2.8 Becton Dickinson
    • 2.8.1 Becton Dickinson Details
    • 2.8.2 Becton Dickinson Major Business
    • 2.8.3 Becton Dickinson Tuberculosis Screening Product and Solutions
    • 2.8.4 Becton Dickinson Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Becton Dickinson Recent Developments and Future Plans
  • 2.9 Abbott
    • 2.9.1 Abbott Details
    • 2.9.2 Abbott Major Business
    • 2.9.3 Abbott Tuberculosis Screening Product and Solutions
    • 2.9.4 Abbott Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Abbott Recent Developments and Future Plans
  • 2.10 Hologic
    • 2.10.1 Hologic Details
    • 2.10.2 Hologic Major Business
    • 2.10.3 Hologic Tuberculosis Screening Product and Solutions
    • 2.10.4 Hologic Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Hologic Recent Developments and Future Plans
  • 2.11 Roche
    • 2.11.1 Roche Details
    • 2.11.2 Roche Major Business
    • 2.11.3 Roche Tuberculosis Screening Product and Solutions
    • 2.11.4 Roche Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Roche Recent Developments and Future Plans
  • 2.12 Thermo Fischer Scientific
    • 2.12.1 Thermo Fischer Scientific Details
    • 2.12.2 Thermo Fischer Scientific Major Business
    • 2.12.3 Thermo Fischer Scientific Tuberculosis Screening Product and Solutions
    • 2.12.4 Thermo Fischer Scientific Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Thermo Fischer Scientific Recent Developments and Future Plans
  • 2.13 Hain Lifescience
    • 2.13.1 Hain Lifescience Details
    • 2.13.2 Hain Lifescience Major Business
    • 2.13.3 Hain Lifescience Tuberculosis Screening Product and Solutions
    • 2.13.4 Hain Lifescience Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Hain Lifescience Recent Developments and Future Plans
  • 2.14 Epistem
    • 2.14.1 Epistem Details
    • 2.14.2 Epistem Major Business
    • 2.14.3 Epistem Tuberculosis Screening Product and Solutions
    • 2.14.4 Epistem Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Epistem Recent Developments and Future Plans
  • 2.15 Creative Diagnostics
    • 2.15.1 Creative Diagnostics Details
    • 2.15.2 Creative Diagnostics Major Business
    • 2.15.3 Creative Diagnostics Tuberculosis Screening Product and Solutions
    • 2.15.4 Creative Diagnostics Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Creative Diagnostics Recent Developments and Future Plans
  • 2.16 Cepheid
    • 2.16.1 Cepheid Details
    • 2.16.2 Cepheid Major Business
    • 2.16.3 Cepheid Tuberculosis Screening Product and Solutions
    • 2.16.4 Cepheid Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Cepheid Recent Developments and Future Plans
  • 2.17 Siemens Healthineer
    • 2.17.1 Siemens Healthineer Details
    • 2.17.2 Siemens Healthineer Major Business
    • 2.17.3 Siemens Healthineer Tuberculosis Screening Product and Solutions
    • 2.17.4 Siemens Healthineer Tuberculosis Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Siemens Healthineer Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Tuberculosis Screening Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Tuberculosis Screening by Company Revenue
    • 3.2.2 Top 3 Tuberculosis Screening Players Market Share in 2025
    • 3.2.3 Top 6 Tuberculosis Screening Players Market Share in 2025
  • 3.3 Tuberculosis Screening Market: Overall Company Footprint Analysis
    • 3.3.1 Tuberculosis Screening Market: Region Footprint
    • 3.3.2 Tuberculosis Screening Market: Company Product Type Footprint
    • 3.3.3 Tuberculosis Screening Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Tuberculosis Screening Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Tuberculosis Screening Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Tuberculosis Screening Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Tuberculosis Screening Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Tuberculosis Screening Consumption Value by Type (2021-2032)
  • 6.2 North America Tuberculosis Screening Market Size by Application (2021-2032)
  • 6.3 North America Tuberculosis Screening Market Size by Country
    • 6.3.1 North America Tuberculosis Screening Consumption Value by Country (2021-2032)
    • 6.3.2 United States Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Tuberculosis Screening Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Tuberculosis Screening Consumption Value by Type (2021-2032)
  • 7.2 Europe Tuberculosis Screening Consumption Value by Application (2021-2032)
  • 7.3 Europe Tuberculosis Screening Market Size by Country
    • 7.3.1 Europe Tuberculosis Screening Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 7.3.3 France Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Tuberculosis Screening Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Tuberculosis Screening Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Tuberculosis Screening Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Tuberculosis Screening Market Size by Region
    • 8.3.1 Asia-Pacific Tuberculosis Screening Consumption Value by Region (2021-2032)
    • 8.3.2 China Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 8.3.5 India Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Tuberculosis Screening Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Tuberculosis Screening Consumption Value by Type (2021-2032)
  • 9.2 South America Tuberculosis Screening Consumption Value by Application (2021-2032)
  • 9.3 South America Tuberculosis Screening Market Size by Country
    • 9.3.1 South America Tuberculosis Screening Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Tuberculosis Screening Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Tuberculosis Screening Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Tuberculosis Screening Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Tuberculosis Screening Market Size by Country
    • 10.3.1 Middle East & Africa Tuberculosis Screening Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Tuberculosis Screening Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Tuberculosis Screening Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Tuberculosis Screening Market Drivers
  • 11.2 Tuberculosis Screening Market Restraints
  • 11.3 Tuberculosis Screening Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Tuberculosis Screening Industry Chain
  • 12.2 Tuberculosis Screening Upstream Analysis
  • 12.3 Tuberculosis Screening Midstream Analysis
  • 12.4 Tuberculosis Screening Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tuberculosis Screening market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Tuberculosis Screening is crucial for early diagnosis and prevention. Market trends include the adoption of advanced diagnostic technologies, such as molecular assays and point-of-care tests, to improve accuracy and speed of diagnosis. There"s also a growing emphasis on screening in high-risk populations and in regions with a high TB burden.
    This report is a detailed and comprehensive analysis for global Tuberculosis Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tuberculosis Screening market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Tuberculosis Screening market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Tuberculosis Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Tuberculosis Screening market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tuberculosis Screening
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tuberculosis Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen, Sanofi, Oxford Immunotec, BioMerieux, Par Sterile, Bio-Rad Laboratories, Akonni Biosystems, Becton Dickinson, Abbott, Hologic, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Tuberculosis Screening market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Active Tuberculosis
    Latent Tuberculosis
    Market segment by Application
    Hospital
    Clinic
    Diagnostic Center
    Laboratories
    Others
    Market segment by players, this report covers
    Qiagen
    Sanofi
    Oxford Immunotec
    BioMerieux
    Par Sterile
    Bio-Rad Laboratories
    Akonni Biosystems
    Becton Dickinson
    Abbott
    Hologic
    Roche
    Thermo Fischer Scientific
    Hain Lifescience
    Epistem
    Creative Diagnostics
    Cepheid
    Siemens Healthineer
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Tuberculosis Screening product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Tuberculosis Screening, with revenue, gross margin, and global market share of Tuberculosis Screening from 2021 to 2026.
    Chapter 3, the Tuberculosis Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Tuberculosis Screening market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis Screening.
    Chapter 13, to describe Tuberculosis Screening research findings and conclusion.

    Buy now